Mark E. Smolkin

4.5k citations
86 papers · 3.2k · h-index 34

Impact in

  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Cancer Immunotherapy and Biomarkers 11
    • CAR-T cell therapy research 7
    • Immunotherapy and Immune Responses 30
    • T-cell and B-cell Immunology 14
    • Immune Cell Function and Interaction 5

Mark E. Smolkin

83 papers receiving 3.2k citations

Peers

Mark E. Smolkin
Comparison fields: 5 of 133
  • Immunology 1.5k
  • Oncology 1.5k
  • Cancer Research 222
  • Pulmonary and Respiratory Medicine 461
  • Molecular Biology 939
Replace Ivan V. Litvinov with:
Ivan V. Litvinov Canada
Leonardo Resta Italy
José Vassallo Brazil
John C. Morris United States
Rebecca Slack United States
Shigeru Sasaki Japan
Raghav Sundar Singapore
Peter Mallmann Germany
Austin Miller United States
Evan R. Farmer United States
Mark E. Smolkin relative to Ivan V. Litvinov Canada Ivan V. Litvinov's profile →
Citations per field
00.5×1.6×
Ivan V. Litvinov · 1×
Citations per year

Countries citing papers authored by Mark E. Smolkin

Since Specialization
Citations

This map shows the geographic impact of Mark E. Smolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smolkin more than expected).

Fields of papers citing papers by Mark E. Smolkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Smolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smolkin. The network helps show where Mark E. Smolkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Smolkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Smolkin Line = papers co-authored together Mark E. Smolkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012439
2 2007133
3 2009129
4 2016103
5 201695
6 201193
7 200689
8 200488
9 200887
10 200885
11 200677
12 201974
13 201273
14 201168
15 200467
16 200961
17 201252
18 201251
19 201750
20 201948

About Mark E. Smolkin

Mark E. Smolkin is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 86 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (30 papers), vaccines and immunoinformatics approaches (17 papers), T-cell and B-cell Immunology (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.5k citations), Cancer Research (222 citations), Pulmonary and Respiratory Medicine (461 citations) and Molecular Biology (939 citations). Mark E. Smolkin has collaborated with scholars based in United States, Qatar and Netherlands. Frequent co-authors include Craig L. Slingluff, Gina R. Petroni, James W. Patterson, Kimberly A. Chianese‐Bullock, Donna H. Deacon, Lynn T. Dengel, Gulsun Erdag, William W. Grosh, Walter C. Olson and Sofia M. Shea. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Journal of Immunotherapy and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact